Other Species / Isoforms
  WASHC2C (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T6-p
__MMNRTtPDQELVP
0 2
WASHC2C (human) __MMNRTtPDQELVP T6-p
WASHC2C iso2 (human) __MMNRTTPDQELVP T6
S24-p
PVWERPWsVEEIRRs
0 1
WASHC2C (human) PVWERPWsVEEIRRs S24-p
WASHC2C iso2 (human) PVWERPWSVEEIRRS S24
S31-p
sVEEIRRssQsWSLA
0 1
WASHC2C (human) sVEEIRRssQsWSLA S31-p
WASHC2C iso2 (human) SVEEIRRSSQSWSLA S31
S32-p
VEEIRRssQsWSLAA
0 1
WASHC2C (human) VEEIRRssQsWSLAA S32-p
WASHC2C iso2 (human) VEEIRRSSQSWSLAA S32
S34-p
EIRRssQsWSLAADA
0 1
WASHC2C (human) EIRRssQsWSLAADA S34-p
WASHC2C iso2 (human) EIRRSSQSWSLAADA S34
S158-p
LDIKAGNsDsEEDDA
0 29
WASHC2C (human) LDIKAGNsDsEEDDA S158-p
WASHC2C iso2 (human) LDIKAGNSDSEEDDA S150
S160-p
IKAGNsDsEEDDANG
0 29
WASHC2C (human) IKAGNsDsEEDDANG S160-p
WASHC2C iso2 (human) IKAGNSDSEEDDANG S152
S284-p
ENTRPKRsRPtsFAD
Upstream
0 94
Treatment
  • angiotensin_2
  • dasatinib
  • EGF
  • lapatinib
  • SB202190
  • SII_angiotensin_2
  • U0126
view more >
WASHC2C (human) ENTRPKRsRPtsFAD S284-p
WASHC2C iso2 (human) ENTRPKRSRPTSFAD S276
T287-p
RPKRsRPtsFADELA
Upstream
0 27
Treatment
  • EGF
  • lapatinib
WASHC2C (human) RPKRsRPtsFADELA T287-p
WASHC2C iso2 (human) RPKRSRPTSFADELA T279
S288-p
PKRsRPtsFADELAA
Upstream
0 140
Treatment
  • angiotensin_2
  • dasatinib
  • EGF
  • lapatinib
  • selumetinib
  • SII_angiotensin_2
  • vemurafenib
view more >
WASHC2C (human) PKRsRPtsFADELAA S288-p
WASHC2C iso2 (human) PKRSRPTSFADELAA S280
T311-p
RVDEEPTtLPsGEAK
0 1
WASHC2C (human) RVDEEPTtLPsGEAK T311-p
WASHC2C iso2 (human) RVDEEPTTLPSGEAK T303
S314-p
EEPTtLPsGEAKPRK
Upstream
0 5
Treatment
  • nocodazole
WASHC2C (human) EEPTtLPsGEAKPRK S314-p
WASHC2C iso2 (human) EEPTTLPSGEAKPRK S306
T331-p
KEKKERRtPsDDEED
0 42
WASHC2C (human) KEKKERRtPsDDEED T331-p
WASHC2C iso2 (human) KEKKERRTPSDDEED T323
S333-p
KKERRtPsDDEEDNL
Upstream
0 65
Treatment
  • metformin
  • SII_angiotensin_2
WASHC2C (human) KKERRtPsDDEEDNL S333-p
WASHC2C iso2 (human) KKERRTPSDDEEDNL S325
S352-p
KLTDEDFsPFGsGGG
Upstream
0 42
Regulatory protein:
  • EGFR (human)
Treatment
  • antibody
  • lapatinib
  • metastatic potential
  • nocodazole
  • vemurafenib
view more >
WASHC2C (human) KLTDEDFsPFGsGGG S352-p
WASHC2C iso2 (human) KLTDEDFSPFGSGGG S344
S356-p
EDFsPFGsGGGLFSG
Upstream
0 12
Treatment
  • BI2536
WASHC2C (human) EDFsPFGsGGGLFSG S356-p
WASHC2C iso2 (human) EDFSPFGSGGGLFSG S348
S375-p
FDDEDEEsDLFTEAs
Upstream
0 4
Treatment
  • BI2536
WASHC2C (human) FDDEDEEsDLFTEAs S375-p
WASHC2C iso2 (human) FDDEDEESDLFTEAS S367
S382-p
sDLFTEAsQDRQAGA
0 3
WASHC2C (human) sDLFTEAsQDRQAGA S382-p
WASHC2C iso2 (human) SDLFTEASQDRQAGA S374
K402-ac
SSSSKPGkKIPAGAV
0 2
WASHC2C (human) SSSSKPGkKIPAGAV K402-ac
WASHC2C iso2 (human) SSSSKPGKKIPAGAV K394
S426-p
FGAAsVPsLKEPQKP
0 1
WASHC2C (human) FGAAsVPsLKEPQKP S426-p
WASHC2C iso2 (human) FGAASVPSLKEPQKP S418
S410-p
KIPAGAVsVFLGDtD
0 1
WASHC2C (human) KIPAGAVsVFLGDtD S410-p
WASHC2C iso2 (human) KIPAGAVSVFLGDTD S402
T416-p
VsVFLGDtDVFGAAs
0 1
WASHC2C (human) VsVFLGDtDVFGAAs T416-p
WASHC2C iso2 (human) VSVFLGDTDVFGAAS T408
S423-p
tDVFGAAsVPsLKEP
0 1
WASHC2C (human) tDVFGAAsVPsLKEP S423-p
WASHC2C iso2 (human) TDVFGAASVPSLKEP S415
T437-p
PQKPEQPtPRKsPYG
0 18
WASHC2C (human) PQKPEQPtPRKsPYG T437-p
WASHC2C iso2 (human) PQKPEQPTPRKSPYG T429
S441-p
EQPtPRKsPYGPPPT
0 18
WASHC2C (human) EQPtPRKsPYGPPPT S441-p
WASHC2C iso2 (human) EQPTPRKSPYGPPPT S433
S478-p
SKTRKVQsTADIFGD
Upstream
0 9
Treatment
  • EGF
  • ischemia
  • SB202190
  • U0126
view more >
WASHC2C (human) SKTRKVQsTADIFGD S478-p
WASHC2C iso2 (human) SKTRKVQSTADIFGD S470
S498-p
FKEKAVAsPEAtVsQ
Upstream
0 29
Treatment
  • MLN8054
  • nocodazole
WASHC2C (human) FKEKAVAsPEAtVsQ S498-p
WASHC2C iso2 (human) FKEKAVASPEATVSQ S490
T502-p
AVAsPEAtVsQTDEN
0 3
WASHC2C (human) AVAsPEAtVsQTDEN T502-p
WASHC2C iso2 (human) AVASPEATVSQTDEN T494
S504-p
AsPEAtVsQTDENKA
Upstream
0 4
Treatment
  • MLN8054
WASHC2C (human) AsPEAtVsQTDENKA S504-p
WASHC2C iso2 (human) ASPEATVSQTDENKA S496
S520-p
AEKKVTLsysKNLKP
0 4
WASHC2C (human) AEKKVTLsysKNLKP S520-p
WASHC2C iso2 (human) AEKKVTLSYSKNLKP S512
Y521-p
EKKVTLsysKNLKPS
0 2
WASHC2C (human) EKKVTLsysKNLKPS Y521-p
WASHC2C iso2 (human) EKKVTLSYSKNLKPS Y513
S522-p
KKVTLsysKNLKPSs
0 3
WASHC2C (human) KKVTLsysKNLKPSs S522-p
WASHC2C iso2 (human) KKVTLSYSKNLKPSS S514
S529-p
sKNLKPSsETKTQKG
Upstream
0 2
Treatment
  • nocodazole
WASHC2C (human) sKNLKPSsETKTQKG S529-p
WASHC2C iso2 (human) SKNLKPSSETKTQKG S521
S539-p
KTQKGLFsDEEDsED
Upstream
0 35
Regulatory protein:
  • TBK1 (human)
Treatment
  • antibody
  • ischemia
  • metastatic potential
view more >
WASHC2C (human) KTQKGLFsDEEDsED S539-p
WASHC2C iso2 (human) KTQKGLFSDEEDSED S531
S544-p
LFsDEEDsEDLFSsQ
0 8
WASHC2C (human) LFsDEEDsEDLFSsQ S544-p
WASHC2C iso2 (human) LFSDEEDSEDLFSSQ S536
S550-p
DsEDLFSsQsAsNLK
0 2
WASHC2C (human) DsEDLFSsQsAsNLK S550-p
WASHC2C iso2 (human) DSEDLFSSQSASNLK S542
S552-p
EDLFSsQsAsNLKGA
0 2
WASHC2C (human) EDLFSsQsAsNLKGA S552-p
WASHC2C iso2 (human) EDLFSSQSASNLKGA S544
S554-p
LFSsQsAsNLKGASL
0 1
WASHC2C (human) LFSsQsAsNLKGASL S554-p
WASHC2C iso2 (human) LFSSQSASNLKGASL S546
S571-p
GKLPTSVsLFDDEDE
0 7
WASHC2C (human) GKLPTSVsLFDDEDE S571-p
WASHC2C iso2 (human) GKLPTSVSLFDDEDE S563
S594-p
AAKKQTLsLQAQREE
0 1
WASHC2C (human) AAKKQTLsLQAQREE S594-p
WASHC2C iso2 (human) AAKKQTLSLQAQREE S586
S619-p
KASALLFssDEEDQW
Upstream
0 11
Treatment
  • metformin
WASHC2C (human) KASALLFssDEEDQW S619-p
WASHC2C iso2 (human) KASALLFSSDEEWNI S611
S620-p
ASALLFssDEEDQWN
Upstream
0 10
Treatment
  • metformin
WASHC2C (human) ASALLFssDEEDQWN S620-p
WASHC2C iso2 (human) ASALLFSSDEEWNIP S612
S663-p
AKAVKKTsLFEEDKE
Upstream
0 2
Treatment
  • vemurafenib
WASHC2C (human) AKAVKKTsLFEEDKE S663-p
WASHC2C iso2 (human) AKAVKKTSLFEEDKE S653
S688-p
QKKTQRVsLLFEDDV
0 1
WASHC2C (human) QKKTQRVsLLFEDDV S688-p
WASHC2C iso2 (human) QKKTQRVSLLFEDDV S678
S728-p
EAPPLLFsDEEEKEA
Upstream
0 26
Treatment
  • nocodazole
WASHC2C (human) EAPPLLFsDEEEKEA S728-p
WASHC2C iso2 (human) EAPPLLFSDEEEKEA S718
S752-p
KVESAKEsLKFGRTD
0 3
WASHC2C (human) KVESAKEsLKFGRTD S752-p
WASHC2C iso2 (human) KVESAKESLKFGRTD S742
K798-ac
KGTKPRTkTVLsLFD
0 1
WASHC2C (human) KGTKPRTkTVLsLFD K798-ac
WASHC2C iso2 (human) KGTKPRTKTVLSLFD K788
S802-p
PRTkTVLsLFDEEED
Upstream
0 32
Treatment
  • EGF
  • U0126
WASHC2C (human) PRTkTVLsLFDEEED S802-p
WASHC2C iso2 (human) PRTKTVLSLFDEEED S792
S909-p
RVVKKDHsVNsFKNQ
0 5
WASHC2C (human) RVVKKDHsVNsFKNQ S909-p
WASHC2C iso2 (human) RVVKKDHSVNSFKNQ S899
S912-p
KKDHsVNsFKNQKHP
0 6
WASHC2C (human) KKDHsVNsFKNQKHP S912-p
WASHC2C iso2 (human) KKDHSVNSFKNQKHP S902
S925-p
HPESIQGsKEKGIWK
0 1
WASHC2C (human) HPESIQGsKEKGIWK S925-p
WASHC2C iso2 (human) HPESIQGSKEKGIWK S915
S1053-p
RRLAAQEssEAEDMs
Upstream
0 7
Treatment
  • angiotensin_2
  • nocodazole
  • SII_angiotensin_2
view more >
WASHC2C (human) RRLAAQEssEAEDMs S1053-p
WASHC2C iso2 (human) RRLAAQESSEAEDMS S1022
S1054-p
RLAAQEssEAEDMsV
Upstream
0 11
Treatment
  • angiotensin_2
  • nocodazole
  • SII_angiotensin_2
view more >
WASHC2C (human) RLAAQEssEAEDMsV S1054-p
WASHC2C iso2 (human) RLAAQESSEAEDMSV S1023
S1060-p
ssEAEDMsVPRGPIA
0 1
WASHC2C (human) ssEAEDMsVPRGPIA S1060-p
WASHC2C iso2 (human) SSEAEDMSVPRGPIA S1029
S1075-p
QWADGAIsPNGHRPQ
Upstream
0 25
Treatment
  • BI_4834
  • nocodazole
WASHC2C (human) QWADGAIsPNGHRPQ S1075-p
WASHC2C iso2 (human) QWADGAISPNGHRPQ S1044
S1087-p
RPQLRAAsGEDSTEE
0 2
WASHC2C (human) RPQLRAAsGEDSTEE S1087-p
WASHC2C iso2 (human) RPQLRAASGEDSTEE S1056
T1113-p
GPVPGVDtsPFAKsL
0 1
WASHC2C (human) GPVPGVDtsPFAKsL T1113-p
WASHC2C iso2 (human) GPVPGVDTSPFAKSL T1082
S1114-p
PVPGVDtsPFAKsLG
0 1
WASHC2C (human) PVPGVDtsPFAKsLG S1114-p
WASHC2C iso2 (human) PVPGVDTSPFAKSLG S1083
S1119-p
DtsPFAKsLGHsRGE
Upstream
0 2
Treatment
  • BI2536
WASHC2C (human) DtsPFAKsLGHsRGE S1119-p
WASHC2C iso2 (human) DTSPFAKSLGHSRGE S1088
S1123-p
FAKsLGHsRGEADLF
0 3
WASHC2C (human) FAKsLGHsRGEADLF S1123-p
WASHC2C iso2 (human) FAKSLGHSRGEADLF S1092
S1169-p
PVGGKAKsPMFPALG
Upstream
0 12
Treatment
  • nocodazole
WASHC2C (human) PVGGKAKsPMFPALG S1169-p
WASHC2C iso2 (human) PVGGKAKSPMFPALG S1138
S1179-p
FPALGEAssDDDLFQ
Upstream
0 16
Treatment
  • nocodazole
WASHC2C (human) FPALGEAssDDDLFQ S1179-p
WASHC2C iso2 (human) FPALGEASSDDDLFQ S1148
S1180-p
PALGEAssDDDLFQS
Upstream
0 19
Treatment
  • nocodazole
WASHC2C (human) PALGEAssDDDLFQS S1180-p
WASHC2C iso2 (human) PALGEASSDDDLFQS S1149